MINNEAPOLIS, Feb. 18 /PRNewswire-FirstCall/ -- Biotel Inc. announced results for its second quarter ended December 31, 2009, with a net loss of ($47,000), or (0.02) per diluted share, on revenues of $2,452,000. This compares to net earnings of $289,000, or $0.10 per diluted share, on revenues of $3,186,000 for the second quarter of last year. For the six months ended December 31, 2009, Biotel had net earnings of $81,000, or $0.03 per diluted share, on revenues of $5,175,000. This compares to net earnings of $617,000, or $0.22 per diluted share, on revenues of $6,354,000 for the first six months of last year.
Highlights for the second quarter are as follows:
“A 23% decrease in second quarter revenues was primarily the result of significantly diminished sales of Braemar’s ER920W wireless event recorder following announcement of Biotel’s planned merger with CardioNet, Inc. and the subsequent termination of that agreement by CardioNet,” Biotel President and CEO Steve Springrose said. “Biotel incurred additional legal expenses in the second quarter of fiscal 2010 related to the two matters as identified above. We expect to continue to incur a significant level of legal expenses during the next twelve months and have elected to expense those fees as incurred. Looking ahead, Braemar expects that wireless product revenues will remain diminished in the second half of the fiscal year.”
Biotel serves as a development partner to medical corporations seeking new devices and clinical research services.
CONTACT: Judy Naus of Biotel Inc., +1-651-286-8623, info@biotelinc.com
Web site: http://www.biotelinc.com/
